Performance Measure: Housing Status

National Quality Forum #: None

Description: Percentage of patients who were homeless or unstably housed in the measurement period

Numerator: Number of patients with an HIV diagnosis who were homeless or unstably housed in the 12-month measurement period

Denominator: Number of patients with an HIV diagnosis receiving HIV services in the last 12 months

Patient Exclusions: None

Data Elements:

  1. Does the patient have a diagnosis of HIV? (Y/N)
    1. Did the patient have at least one HIV service during the measurement year? (Y/N)
      1. Was the patient homeless or unstably housed? (Y/N)

Comparison data

This HIV/AIDS Bureau measure aligns with the National HIV/AIDS Strategy (2022-2025) Indicator 8: Reduce homelessness. Baseline result 9.1% (2017); target by 2025, reduce by 50%.

The HIV Quality Measures (HIVQM) Module is a tool within the Ryan White HIV/AIDS Services Report portal. It allows recipients to enter aggregate data specific to HRSA HAB Performance Measures. The HIVQM Module allows recipients to conduct point-in-time benchmarking across Ryan White HIV/AIDS Programs that use the module.

Department of Health and Human Services Clinical Practice Guidelines

Adult guidelines

"Patients living with HIV infection often must cope with many social, psychiatric, and medical issues that are best addressed through a patient-centered, multidisciplinary approach to the disease. The baseline evaluation should include an evaluation of the patient’s readiness for ART, including an assessment of high-risk behaviors, substance abuse, social support, mental illness, comorbidities, economic factors (e.g., unstable housing), medical insurance status and adequacy of coverage, and other factors that are known to impair adherence to ART and increase the risk of HIV transmission. Once evaluated, these factors should be managed accordingly. The baseline evaluation should also include a discussion of risk reduction and disclosure to sexual and/or needle sharing partners, especially with untreated patients who are still at high risk of transmission."1

Use in other federal programs


1 Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV (PDF - 4 MB). Department of Health and Human Services. Available online. Accessed August 2022. B-1.

Date Last Reviewed: